These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 20362557)
1. Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma. Archer CR; Koomoa DL; Mitsunaga EM; Clerc J; Shimizu M; Kaiser M; Schellenberg B; Dudler R; Bachmann AS Biochem Pharmacol; 2010 Jul; 80(2):170-8. PubMed ID: 20362557 [TBL] [Abstract][Full Text] [Related]
2. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells. Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914 [TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related]
6. The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells. Baumann P; Müller K; Mandl-Weber S; Leban J; Doblhofer R; Ammendola A; Baumgartner R; Oduncu F; Schmidmaier R Br J Haematol; 2009 Mar; 144(6):875-86. PubMed ID: 19170678 [TBL] [Abstract][Full Text] [Related]
7. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Frankel A; Man S; Elliott P; Adams J; Kerbel RS Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766 [TBL] [Abstract][Full Text] [Related]
8. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105 [TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer. Shi YY; Small GW; Orlowski RZ Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678 [TBL] [Abstract][Full Text] [Related]
11. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma. Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006 [TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade. Yerlikaya A; Erin N Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781 [TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
15. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gossner G; Choi M; Tan L; Fogoros S; Griffith KA; Kuenker M; Liu JR Gynecol Oncol; 2007 Apr; 105(1):23-30. PubMed ID: 17234261 [TBL] [Abstract][Full Text] [Related]
16. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Yang X; Fraser M; Moll UM; Basak A; Tsang BK Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663 [TBL] [Abstract][Full Text] [Related]
17. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells. Yang M; Huang J; Pan HZ; Jin J Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis. Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905 [TBL] [Abstract][Full Text] [Related]
19. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Shankar S; Srivastava RK Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930 [TBL] [Abstract][Full Text] [Related]
20. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent. Yang B; Reynolds CP Clin Cancer Res; 2005 Apr; 11(7):2774-80. PubMed ID: 15814660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]